Cyclosporine in Cardiac Transplantation
- 1 June 1985
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 65 (3) , 637-659
- https://doi.org/10.1016/s0039-6109(16)43641-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- CLINICAL SIGNIFICANCE OF IN SITU DETECTION OF T LYMPHOCYTE SUBSETS AND MONOCYTE/MACROPHAGE LINEAGES IN HEART ALLOGRAFTSTransplantation, 1984
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- Monoclonality of Lymphoproliferative Lesions in Cardiac-Transplant RecipientsNew England Journal of Medicine, 1984
- Cyclosporine-Associated Central-Nervous-System Toxicity after Allogeneic Bone-Marrow TransplantationNew England Journal of Medicine, 1984
- CYCLOSPORINE AND KETOCONAZOLETransplantation, 1984
- Nephrotoxicity of Cyclosporin a after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1981
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- REVERSAL OF ACUTE REJECTION EPISODES BY CYCLOSPORIN A IN DOGS RECEIVING RENAL ALLOGRAFTSTransplantation, 1980
- MALIGNANT LYMPHOMA IN CYCLOSPORIN A TREATED ALLOGRAFT RECIPIENTSThe Lancet, 1980
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979